002162 Everjoy Health Group
- 2.85
- +0.09+3.26%
Everjoy Health Group News
Yuexin Health (002162): After mergers, acquisitions and restructuring, a big health pattern is beginning to appear
Yuexin Health (002162) interim report review: The main ceramic tile industry is growing steadily, and the transformation of the health industry continues to advance
Yuexin Health (002162) Review: The acquisition of three private hospitals and the transformation of Big Health is progressing steadily!
Yuexin Health (002162) three-quarter report comments: ceramic tile business steady growth into a transformation of great health and solid backing
[Societe Generale Securities] comment on Yuexin Health 2016 three-quarter report: ceramic tile business grows steadily and becomes a healthy and solid backing for transformation.
Smick (002162) Research Report: When the transformation is underway, the health board is in line with current national conditions and the future looks at the pension industry
[Xiangcai Securities] Smick: When the transformation is underway, the health board is in line with current national conditions, and the future depends on the pension industry
Smick (002162) Company Research: If you get the fragrant scent of plum blossoms, you still need a bit of pride
[Xiangcai Securities] Smick Research brief: all you need is "volume"
[Dongxing Securities] Smick Research Express: Brand restructuring is about to enter a harvest period, lithium ore resources are undervalued
【天相投资】斯米克:房产销量和成本压力影响第四季业绩表现
【天相投资】斯米克:期待陶瓷业务和锂土开发新表现和进展
【天相投资】斯米克:产能释放摊低成本,二季销售低于预期
【中银国际】斯米克:期待产能释放及新资源项目
【天相投资】斯米克:经营业绩改善下季节性亏损依旧
【第一创业证券】斯米克:江西产能释放,力拓中端市场
【天相投资】斯米克:稳高扩中,产能释放提升未来业绩
【第一创业证券】斯米克:产能释放拉动10年业绩大幅改善
【天相投资】斯米克:业绩继续反转向上,前三季度净利润仍下降67%
【天相投资】斯米克：高端市场领导，毛利率逆市提升
Analysis
Price Target
No Data
